Skip to main content
. 2016 Nov 21;28(2):376–383. doi: 10.1007/s13361-016-1544-4

Table 1.

Clinic-Pathological Characteristics of the Patient Series

High grade leiomyosarcoma High grade myxofibrosarcoma High grade undifferentiated pleomorphic sarcoma High grade osteosarcoma
No. of patients 8 10 8 7
Gender Male versus female 4 versus 4 3 versus 7 6 versus 2 4 versus 3
Age Median (y) 60.1 74.0 69.5 21.0
Therapy Neoadjuvant treatment 1 / 8 0 / 10 1 / 8 5/ 7
Adjuvant treatment 7 / 8 6 / 10 5 / 8 6 / 7
Length of follow-up Median overall survival (mo) 25.3 64% survival probability at max. follow-up time (103.2 mo) 21.5 28.5
Median metastasis-free survival (mo) 10.2 73% metastasis-free probability at max. follow-up time (52.0 mo) 11.1 9.5